By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — The UK Centre for Medical Research and Innovation will maintain "a strong focus" on cancer, heart disease, and stroke as well as disorders of the immune system and later-life diseases of the nervous system, according to a scientific vision and research strategy outline made public by partners in the planned £600 million institute.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.